Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains

Neuroscience Letters

Volumn 320, Issue 1-2, 2002, Pages 25-28

  Ghebremedhin, Estifanos ^a   Thal, Dietmar R ^b   Schultz, Christian ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Alzheimer disease; Alzheimer disease neuropathology; Apolipoprotein E; Butyrylcholinesterase; Genetic association; K variant

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; CHOLINESTERASE; CHOLINESTERASE K; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PREVALENCE; PRIORITY JOURNAL;

EID: 0036498992     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00014-9     Document Type: Article

References (20)

1. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites
2. Frequency of stages of Alzheimer-related lesions in different age categories
3. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families
4. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations
5. Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens
6. High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes
7. Gender and age modify the association between ApoE and AD-related neuropathology
8. Analysis of association between Alzheimer disease and the K variant of butyrylcholinesterase (BCHE-K)
9. Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the national institute on aging and the Reagan institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease
10. Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site
11. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
12. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease
13. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland
14. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia
15. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes
16. Changes in brain cholinesterases in senile dementia of Alzheimer type
17. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease
18. No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease
19. Sequence of Aβ-Protein deposition in the human medial temporal lobe
20. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease